The APDN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APDN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The APDN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View APDN Detailed Price Forecast - CNN Money||View APDN Detailed Summary - Google Finance|
|View APDN Detailed Summary - Yahoo! Finance||View APDN Stock Research & Analysis - Zacks.com|
|View APDN Trends & Analysis - Trade-Ideas||View APDN Major Holders - Barrons|
|View APDN Call Transcripts - NASDAQ||View APDN Breaking News & Analysis - Seeking Alpha|
|View APDN Annual Report - CompanySpotlight.com||View APDN OTC Short Report - OTCShortReport.com|
|View APDN Fundamentals - TradeKing||View APDN SEC Filings - Bar Chart|
|View Historical Prices for APDN - The WSJ||View Performance/Total Return for APDN - Morningstar|
|View the Analyst Estimates for APDN - MarketWatch||View the Earnings History for APDN - CNBC|
|View the APDN Earnings - StockMarketWatch||View APDN Buy or Sell Recommendations - MacroAxis|
|View the APDN Bullish Patterns - American Bulls||View APDN Short Pain Metrics - ShortPainBot.com|
|View APDN Stock Mentions - StockTwits||View APDN Stock Mentions - PennyStockTweets|
|View APDN Stock Mentions - Twitter||View APDN Investment Forum News - Investor Hub|
|View APDN Stock Mentions - Yahoo! Message Board||View APDN Stock Mentions - Seeking Alpha|
|View Insider Transactions for APDN - SECform4.com||View Insider Transactions for APDN - Insider Cow|
|View APDN Major Holdings Summary - CNBC||View Insider Disclosure for APDN - OTC Markets|
|View Insider Transactions for APDN - Yahoo! Finance||View Institutional Holdings for APDN - NASDAQ|
|View APDN Stock Insight & Charts - FinViz.com||View APDN Investment Charts - StockCharts.com|
|View APDN Stock Overview & Charts - BarChart||View APDN User Generated Charts - Trading View|
Applied DNA Expands Cannabis Tagging Portfolio to Address Large Growers
Posted on Tuesday September 25, 2018
Applied DNA Sciences Inc. (APDN) (“Applied DNA” or the “Company”) announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution. The Company’s laboratory services and in-field testing systems round out the solution to support claims of traceability, quality and intellectual properties surrounding a cannabis brand. “The tremendous interest that came following the show has really accelerated our expansion of tagging solutions to meet the varied cannabis market conditions, including size of grower, indoor, outdoor or hybrid grow, or even the size of plant(s) that justifies the expansion of our tagging equipment solutions,” said Gordon Hope, Director of Cannabis Business Development at Applied DNA Sciences.
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
Posted on Thursday September 20, 2018
Applied DNA Sciences Inc. (APDN) (“Applied DNA” or the “Company”) announced today that LineaRx, Inc. (“LineaRx”), its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement (the “Agreement”) with Takis S.R.L. and Evvivax S.R.L. (“Takis/Evvivax”), biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively. Under the terms of the Agreement, LineaRx and Takis/Evvivax will jointly develop linear DNA expression vectors for two of Takis/Evvivax’s anti-cancer vaccine candidates utilizing LineaRx’s linear DNA technology.
Applied DNA Forms Wholly Owned Subsidiary, LineaRx, to Develop Large-Scale, PCR-Produced DNA for Biotherapeutics
Posted on Tuesday September 18, 2018
Applied DNA Sciences Inc., (NASDAQ: APDN, “Applied DNA” or the “Company”), the leader in large-scale PCR-based DNA manufacturing, announced today the formation of LineaRx, Inc., a wholly owned subsidiary. Its purpose is to commercialize the Company’s extensive experience in the design, manufacture and chemical modification of DNA by large scale polymerase chain reaction (“PCR”) in the field of biotherapeutics, specifically gene and cellular therapies as well as vaccines. The Company believes that the opportunity and markets for these biotherapeutics are substantial, and that its proprietary PCR technology offers the potential for improved outcomes relative to current plasmid and viral vector production technologies.
Applied DNA Executes New Two-Year Contract with the U.S. Defense Logistics Agency
Posted on Tuesday September 11, 2018
Applied DNA Sciences Inc., (NASDAQ:APDN, “Applied DNA,”), the leader in large-scale PCR-based DNA manufacturing, announced today the signing of a new contract to continue uninterrupted service of the Company’s DNA marking program at the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) in Columbus, Ohio. The contract outlines the Company’s provision of supplies and services, including creation of unique DNA marks in various inks, QC authentication testing and training. “We appreciate the DLA’s continuing support of our taggant technology platform in extending this contract for the marking of system-critical microcircuits,” stated Janice Meraglia, Vice President of Government and Military Programs at Applied DNA.